Showing results (1231-1240 of 5,986) with videos related to

Sort By:
Pageof 599
Molecular Cancer Therapeutics|May 2, 2019
IL15-Based Trifunctional Antibody-Fusion Proteins with Costimulatory TNF-Superfamily Ligands in the Single-Chain Format for Cancer ImmunotherapyNadine Beha, Markus Harder, Sarah Ring, et al.
Molecular Cancer Therapeutics|November 2, 2021
Association of Homologous Recombination-DNA Damage Response Gene Mutations with Immune Biomarkers in Gastroesophageal CancersMichael Cerniglia, Joanne Xiu, Axel Grothey, et al.
Molecular Cancer Therapeutics|January 28, 2022
Functional Genomic Identification of Predictors of Sensitivity and Mechanisms of Resistance to Multivalent Second-Generation TRAIL-R2 AgonistsVera Grinkevitch, Mark Wappett, Nyree Crawford, et al.
Molecular Cancer Therapeutics|March 21, 2022
Porcupine Inhibition Disrupts Mitochondrial Function and Homeostasis in WNT Ligand-Addicted Pancreatic CancerKristina Y Aguilera, Thuc Le, Rana Riahi, et al.
Molecular Cancer Therapeutics|September 6, 2018
Shedding Light on the Dark Cancer Genomes: Long Noncoding RNAs as Novel Biomarkers and Potential Therapeutic Targets for CancerLin Zhang, Dan Peng, Anil K Sood, et al.
Molecular Cancer Therapeutics|September 6, 2018
We're Not "DON" Yet: Optimal Dosing and Prodrug Delivery of 6-Diazo-5-oxo-L-norleucineKathryn M Lemberg, James J Vornov, Rana Rais, et al.
Molecular Cancer Therapeutics|September 8, 2018
Interleukin-24 (IL24) Is Suppressed by PAX3-FOXO1 and Is a Novel Therapy for RhabdomyosarcomaAlexandra Lacey, Erik Hedrick, Yating Cheng, et al.
Molecular Cancer Therapeutics|October 5, 2018
Association of Imatinib Plasma Concentration and Single-nucleotide Polymorphisms with Adverse Drug Reactions in Patients with Gastrointestinal Stromal TumorsQiang Zhang, Jianghao Xu, Yi Qian, et al.
Molecular Cancer Therapeutics|September 13, 2018
Sprague DawleyFallon K Noto, Valeriya Adjan-Steffey, Min Tong, et al.
Molecular Cancer Therapeutics|October 12, 2018
A Four-gene Decision Tree Signature Classification of Triple-negative Breast Cancer: Implications for Targeted TherapeuticsJelmar Quist, Hasan Mirza, Maggie C U Cheang, et al.
Pageof 599